Russell Investments Group, Ltd.
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1692234
Seattle, WA
Position in VNDA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$607,617
+$73,650 QoQ
Shares Held
99,284
+28.5% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. VNDA ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $607,617 | 99,284 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $533,967 | 77,275 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $549,069 | 62,253 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $32,409 | 6,495 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,508 | 1,167 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $74,283 | 16,184 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $169,445 | 35,375 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $251,031 | 53,525 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $354,971 | 62,827 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $256,836 | 62,491 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $301,647 | 71,481 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $421,734 | 97,624 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $276,204 | 41,913 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $280,331 | 41,286 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $909,116 | 123,020 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $933,470 | 94,481 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $443,334 | 40,673 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $570,169 | 50,413 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,312,245 | 83,636 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $1,870,795 | 109,148 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 ALXN | — | 216,189 | Shares | Defined | 2021-08-04 | |
| 2021-06-30 | $2,728,757 | 126,860 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 ALXN | — | 235,010 | Shares | Defined | 2021-05-10 | |
| 2021-03-31 | $3,287,335 | 218,864 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 ALXN | — | 275,925 | Shares | Defined | 2021-02-08 | |
| 2020-12-31 | $3,828,982 | 291,399 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 ALXN | — | 291,276 | Shares | Defined | 2020-11-09 | |
| 2020-09-30 | $3,453,728 | 357,529 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 ALXN | — | 297,604 | Shares | Defined | 2020-08-05 | |
| 2020-06-30 | $1,705,795 | 149,108 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 ALXN | — | 240,413 | Shares | Defined | 2020-05-06 | |
| 2020-03-31 | $2,995,343 | 289,126 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||